Baseline risk characterization of early versus later adopters of long‐acting paliperidone palmitate formulations

• Main Authors: Daniel Fife (Author), Stephen Fortin (Author), Hong Qiu (Author), Michiyo Yamazaki (Author), Dean Najarian (Author), Erica A Voss (Author)
• Format: Book
• Published: Wiley, 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Early Post‐Marketing Phase Vigilance (EPPV) is a unique system that encourages reporting of serious adverse reactions for medications newly introduced to Japan. When a once‐monthly paliperidone palmitate formulation (PP1M) was introduced in Japan in 2013, EPPV detected a signal of increased...